Older Individuals Lack Adequate Function of NK Cells and Can Not Expand SNK Cells When Compared to Younger Individuals; Reversal by Infusion of SNKs (UCLA Case No. 2025-018)

Please contact UCLA Technology Development Group for more information.

KEYWORDS: immunotherapy, natural killer cells, cell therapy, immunity, geriatric immune rejuvenation, cancer adjunct therapy, immunosenescence

Patent Information:
For More Information:
Thibault Renac
Business Development Officer
Thibault.Renac@tdg.ucla.edu
Inventors:
Anahid Jewett